UA108990C2 - Use of 4-aminopyridine to improve neuro-cognitive and/or neuro-psychiatric impairment in patients with demyelinating and other nervous system conditions - Google Patents

Use of 4-aminopyridine to improve neuro-cognitive and/or neuro-psychiatric impairment in patients with demyelinating and other nervous system conditions

Info

Publication number
UA108990C2
UA108990C2 UAA201202775A UAA201202775A UA108990C2 UA 108990 C2 UA108990 C2 UA 108990C2 UA A201202775 A UAA201202775 A UA A201202775A UA A201202775 A UAA201202775 A UA A201202775A UA 108990 C2 UA108990 C2 UA 108990C2
Authority
UA
Ukraine
Prior art keywords
neuro
aminopyridine
demyelinating
cognitive
patients
Prior art date
Application number
UAA201202775A
Other languages
Ukrainian (uk)
Inventor
Томас К. ВЕССЕЛЬ
Original Assignee
Акорда Терапьютикс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2010/045211 external-priority patent/WO2011019845A1/en
Application filed by Акорда Терапьютикс, Инк. filed Critical Акорда Терапьютикс, Инк.
Publication of UA108990C2 publication Critical patent/UA108990C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Винахід стосується поліпшення стану при нейрокогнітивному або нейропсихіатричному порушенні у пацієнта, що страждає на розсіяний склероз, що передбачає застосування композиції з уповільненим вивільненням, яка містить 4-амінопіридин, в дозі 10 мг 4-амінопіридину два рази на день.The invention relates to an improvement in the condition of a neurocognitive or neuropsychiatric disorder in a patient suffering from multiple sclerosis, which involves the use of a delayed-release composition containing 4-aminopyridine at a dose of 10 mg 4-aminopyridine twice daily.

UAA201202775A 2009-08-11 2010-11-08 Use of 4-aminopyridine to improve neuro-cognitive and/or neuro-psychiatric impairment in patients with demyelinating and other nervous system conditions UA108990C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23307709P 2009-08-11 2009-08-11
PCT/US2010/045211 WO2011019845A1 (en) 2009-08-11 2010-08-11 Use of 4-aminopyridine to improve neuro-cognitive and/or neuro-psychiatric impairment in patients with demyelinating and other nervous system conditions

Publications (1)

Publication Number Publication Date
UA108990C2 true UA108990C2 (en) 2015-07-10

Family

ID=53717465

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201202775A UA108990C2 (en) 2009-08-11 2010-11-08 Use of 4-aminopyridine to improve neuro-cognitive and/or neuro-psychiatric impairment in patients with demyelinating and other nervous system conditions

Country Status (1)

Country Link
UA (1) UA108990C2 (en)

Similar Documents

Publication Publication Date Title
IL201479A (en) Use of tapentadol for the manufacture of a medicament for the treatment of pain
MY145439A (en) Use of flibanserin for the treatment of pre-menopausal sexual desire disorders
MY151048A (en) Use of flibanserin for the treatment of post-menopausal sexual desire disorders
MX2010004494A (en) Use of trkb antibodies for the treatment of respiratory disorders.
MX2012007375A (en) 3-keto-n-propargyl-1-aminoindan.
MX2010013766A (en) Rasagiline for parkinson's disease modification.
MX2009008051A (en) Dosage regimen for comt inhibitors.
UA104869C2 (en) Normal;heading 1;heading 2;heading 3;PHARMACEUTICAL FORMULATIONS CONTAINING DOPAMINE RECEPTOR LIGANDS
MX2010006823A (en) Methods for the treatment of gout.
MX340822B (en) Formulations for oral delivery of adsorbents in the gut.
WO2012021629A3 (en) Novel d3 dopamine receptor agonists to treat dyskinesia in parkinson's disease
UA98839C2 (en) N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
MX2010002498A (en) Methods of treating or preventing respiratory tract infection comprising administering cholecalciferol.
MY153408A (en) Novel methods
MX2010006204A (en) 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases.
WO2007138466A3 (en) Pharmaceutical compositions comprising meloxicam and tramadol combination
EP2416795A4 (en) Inhibitors of cognitive decline
UA88941C2 (en) Substituted 4-phenyltetrahydroisoquinolines, their use as drug, and drug containing them
UA97401C2 (en) Improved taste-masking extrudates
MX2010001243A (en) Anti-inflammatory composition.
WO2008008882A3 (en) Glucocorticoid receptor modulator and methods of use
TNSN08385A1 (en) Delayed-release glucocorticoid treatment of rheumatoid disease
EP2566502A4 (en) Methods for treating or preventing cardiovascular disorders and providing cardiovascular protection
UA108990C2 (en) Use of 4-aminopyridine to improve neuro-cognitive and/or neuro-psychiatric impairment in patients with demyelinating and other nervous system conditions
MX2009012761A (en) Neramexane for the treatment of nystagmus.